{"symbol":"ABT","fiscalQuarter":"Q2-2017","reportDate":"2017-07-20","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2017","postBrief":{"headline":"Abbott Labs Beats on EPS, Stock Up 2.87%","keyNumbers":[{"metric":"EPS","actual":"$0.62","expected":"N/A","surprise":"+0.76%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS results this quarter.","Our focus remains on delivering innovative products to the market."],"summary":"Management expressed satisfaction with the EPS performance, highlighting their commitment to innovation. They did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Abbott Labs reported a positive surprise in EPS, which contributed to a 2.87% increase in stock price. The lack of revenue data and guidance may leave investors cautious, but the management's focus on innovation suggests a commitment to growth. Overall, the earnings report indicates a solid performance in the current quarter.","metaDescription":"Abbott Labs (ABT) Q2 2017 earnings: EPS beat by 0.76%. Stock up 2.87%. Full breakdown."}}